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Abstract 
 
Background: Memory impairment in behavioral variant frontotemporal dementia (bvFTD) is 
traditionally considered   to be mild and attributed to prefrontal cortex dysfunction. Recent 
studies, however, indicated that some patients can present with a memory impairment of 
the hippocampal type, showing storage and consolidation deficits in addition to the more 
executive/prefrontal related encoding and strategic difficulties. 
 
Objective: This study aimed to study the relationship between executive functions (EF) and 
memory processes in bvFTD via a data-driven approach.  
 
Method: Participants consisted of 71 bvFTD (among which 60.6% had a lumbar puncture 
showing non-Alzheimer biomarker profile) and 60 controls (among which 45% had amyloid 
imaging showing a normal profile). EF were assessed by the Frontal Assessment Battery, 
semantic/lexical verbal fluency tests, and forward/backward digit spans. Patients were split 
into amnestic (n = 33) and non-amnestic (n = 38) subgroups based on normative data (total 
recall score) from the Free and Cued Selective Reminding Test (FCSRT). Relationships 
between FCSRT subscores and EF measures were explored through hierarchical clustering 
analysis, partial correlation analysis with an EF component, and automated linear modeling.  
 
Results: Convergent findings across the statistical approaches show that, overall, memory 
performance was   independent from EF in bvFTD whereas the relationship was stronger in 
controls. Indeed, in bvFTD, memory performance did not cluster with EF, was not correlated 
with the EF component, and was only partially (4%–12.7%) predicted by EF. 
 
Discussion: These findings show that executive dysfunctions cannot solely explain the 
memory deficits occurring in bvFTD. Indeed, some patients present with a genuine amnesia 
affecting storage and consolidation abilities, which are independent from executive 
dysfunctions. On the clinical level, this study highlights the importance of revising the 
neuropsychological diagnosis criteria for bvFTD. 
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Introduction 
 
Clinical  distinction  of  behavioral-variant   frontotemporal  dementia  (bvFTD)  from   
Alzheimer’s disease (AD) has historically relied on a dichotomous view  of  cognitive  
symptoms  in  these syndromes. While the presence of an episodic amnestic syndrome is 
required for the diagnosis of AD [1], diagnostic criteria for bvFTD describes a dysexecutive 
cognitive profile, with relative sparing of memory    functions [2].  There is, however,  an  
ongoing debate in the literature on the usefulness of these two   respective criteria in the 
differential diagnosis of bvFTD    and AD [3, 4]. Indeed, an increasing number of   studies 
have shown that some typical AD patients can present with severe executive dysfunction 
[5–7] and    some bvFTD patients can present with severe amnesia [8, 9], including 
pathologically confirmed cases [10–12]. Similarly, at the pathological level significant pre-
frontal and hippocampal atrophy can be observed in AD and bvFTD, respectively [5, 11, 13]. 
 
Importantly,   however,   executive   function and memory are not independent from each 
other and there is substantial evidence that executive dysfunction can impact on memory 
performance, even when medial temporal lobe areas are relatively spared [14]. Thus, 
memory impairment in bvFTD patients has previously been considered to be secondary to 
significant prefrontal cortex (PFC) dysfunction in these patients. The contribution of  
prefrontal  regions  in episodic memory processing is well established [15, 16] and patients 
with PFC lesions typically exhibit impaired performance in  neuropsychological  memory 
tests, with deficits in free recall, source memory, memory for temporal order, recency, 
frequency, and associative learning (for a review, see [17]). In more detail, poor organization 
of information and lack of efficient learning strategies have been suggested to    explain 
encoding difficulties of PFC patients, whereas  their low  retrieval  performance  has  been  
attributed  to an inability to implement effective retrieval    strategies  [17,  18].  Finally, PFC 
patients often lack of insight into their own memory difficulties and    fail to spontaneously 
use compensatory strategies, akin to bvFTD [19].   
 
One approach to delineate the contribution of executive/PFC mechanisms and 
memory/hippocampal processes is to use memory tests that separate each step of the 
learning, storage, and retrieval procedures. The Free and Cued Selective Reminding Test  
(FCSRT;  [20])  was  designed  specifically  for this purpose, as it uses semantic cueing   for 
controlling effective encoding and facilitating  subsequent cued recall of words, for those 
items that are  not spontaneously retrieved. This procedure allows clinicians to identify 
deficits in specific steps of     learning or retrieval, including associative encoding, free recall, 
cued recall, recognition, delayed free and cued recall. In  particular,  the  performance  in  
cued recall and delayed cued recall is assumed to provide  a ‘purer’ measure of memory 
storage and  consolidation (and thus  tapping  into  hippocampal functioning), while 
encoding and free recall are supposed to   rely more on executive/prefrontal functioning. 
 
Previous studies using the FCSRT in bvFTD have reported encoding and retrieval strategy 
difficulties [21, 22], suggesting that executive dysfunction impacts on memory performance 
in   these patients. More importantly, however, when performance on cued recall and 
delayed recall were also considered, bvFTD patients, although outperforming AD in both 
studies, presented evidence of a   “genuine memory deficit” [21]. These findings suggested 
that bvFTD patients may show significant memory storage and consolidation deficits, in 
addition to   encoding and strategic retrieval difficulties. Studies using different 
neuropsychological memory tests have not replicated these results, instead supporting 
the notion that executive/prefrontal dysfunctions should be considered the main predictor 
of memory impairment in bvFTD [23, 24]. One possible explanation for  this discrepancy is 
that only a proportion of bvFTD patients show “true amnesia” [11]. Indeed, a bi-modal 
distribution of FCSRT performance has been observed in bvFTD patients, with approximately 
50% of    patients presenting with storage and consolidation deficits, while the other half 
showed impairments in encoding and retrieval strategy [9]. 
 
To our knowledge, no previous study has attempted to delineate executive and memory 
dysfunction    in amnestic versus non-amnestic bvFTD. The   current study is aimed at 
addressing this issue by taking    a data-driven approach to investigate the relationship 
between executive task performance and memory scores from the FCSRT in a large group of 
bvFTD patients, the majority of which had biomarker data to support their diagnoses.  To 
explore the impact of executive dysfunction on memory   performance, bvFTD patients were 
split into amnestic versus non-amnestic subgroups and contrasted to age-matched healthy 
controls. 
 
Materials and Methods 
 
Participants 
 
A total of 180 participants were included in   this study.  We  included  bvFTD  patients  with 
memory 
impairment  if  other  core  diagnostic  criteria were present [2]. All bvFTD patients were 
selected  from the  database  of  the  Memory  and  Alzheimer  Institute  of  the  Pitie´-
Salpeˆtrie`re  Hospital  (IM2A  Paris, France). All patients underwent extensive 
neuropsychological  assessment  as  well  as  T1-MRI (and/or SPECT  imaging).  From  an  
initial  sample  of 111 patients, we retained 71 bvFTD patients. A total  of 39 patients were 
excluded from the study    because of missing cognitive data, concomitant motor-neuron 
disease,  vascular  lesions,  or  alcoholism  (n = 17); atypical clinical and imaging evolution  
compatible with  the  diagnosis  of  non-progressive bvFTD—or phenocopy (n = 12); the 
presence of an AD biomarker profile  as  revealed  by  CSF  analyses  following a lumbar 
puncture (n = 8); atypical evolution not     in accordance with initial diagnosis (i.e., clinical   
and cognitive improvement, n = 2). One last patient was excluded because French was not 
his native language.  Of these 71 patients who received a clinical diagnosis of bvFTD on the 
basis of clinical, cognitive and imaging examinations, 60.6% (n = 43) had additional diagnosis 
confirmation either through normal cerebrospinal fluid (CSF) measures of phospho-tau, 
total-tau, and amyloid-þ levels (n = 28), or through positive genetic testing (n = 15).  
 
From  an  initial  sample  of  69  participants,  we retained 60 controls. They were volunteers 
recruited through  the  Biomage  (ANR-07-LVIE-002-01) and Imabio3 studies (PHRC 2010) in 
France (n = 27) or through the Cognitive Neurology and Dementia Unit, Hospital del 
Salvador, University of Chile (n = 33). Among the original sample (n = 69), 100% underwent a 
neuropsychological examination and a T1 MRI and 43.5% (n = 30) underwent 11C-PiB-PET 
imaging. On the basis of these examinations, we excluded 6 controls with abnormal atrophy 
of the brain or significant vascular signs and 3 controls with positive  amyloid imaging (global 
11C-PiB >1.4). Among the controls who underwent the amyloid imaging, all other  
participants had a negative amyloid imaging defined by 
a global 11C-PiB retention lower than 1.4. No differences were observed on age, education, 
and screening (Frontal Assessment Battery (FAB) and Mini-Mental State Examination) 
measures between French    and Chilean controls.  
 
Biological and clinical data of patients were  collected during the routine clinical workup and   
were retrospectively  extracted  for  the  purpose  of   this work. The ethics and scientific 
committees of     the East  Metropolitan  Health  Service,  Chile  University  (Chile)  and  Pitié-
Salpêtrière hospital  (France) approved the recruitment and testing of controls and all 
provided written informed consent. 
 
Assessment of memory 
 
All participants underwent the FCSRT, a memory test based on a semantic cueing method 
that controls for effective encoding of 16 words and facilitates retrieval by semantic cueing. 
Immediate cued recall was tested in a first phase to control for encoding (Encoding score). 
Then, the memory phase was performed in three successive trials. Each trial included a free 
recall attempt consisting of spontaneous recall of as many items as possible, then a cued 
recall attempt using an aurally presented semantic category for items that were not 
spontaneously retrieved   by the patients. The same semantic cue given     during the initial 
encoding stage was used. This    provided a free recall score and a cued recall score 
(maximum  score = 48).  We  computed  a  percentage of sensitivity to cues (free recall score 
– total recall score)/(total recall score – 48). Following a delay of 30 min, a final recall trial 
was performed, providing free and cued delayed recall scores (maximum score 
= 16). Based on cut-offs recommended by normative data for the FCSRT (total recall score), 
bvFTD   patients were divided into subgroups of patients   presenting with an ‘amnesic’ 
profile (n = 33, amnestic-bvFTD) and a ‘non-amnesic’ profile (n = 38,  nonAmnestic-bvFTD), 
in line with previously reported procedures [25]. 
 
Assessment of executive functioning 
 
The FAB [26] and phonemic and category fluency tests as well as forward and backward digit 
spans were administered to all participants.  
 
Statistical analyses 
 
Statistical  analyses  were  conducted  with   IBM SPSS 20. Demographic and clinical variables  
were analyzed  using  Mann-Whitney  test  and ANOVAs. All cognitive variables were then 
standardized (transformed to z-scores) based on data from the   control group’s 
performance. 
 
To  determine how closely EF and memory   sub-processes were related, we used a two-step 
approach. As  a  first  step,  hierarchical  cluster  analysis  using Ward’s method was used to 
determine how   closely EF and memory sub-processes were related. Briefly, the cluster 
analysis defines each variable as an individual cluster; clusters are then sequentially merged 
as  per  their  squared  Euclidean  distance  in  a  geometric space where the number of 
variables set   the number of dimensions. The clusters extracted  from the optimal model 
are then plotted on a dendrogram representing  the  relationships  of  similarity among the 
group of variables. As a second step, a principal component analysis was conducted only on   
EF measures, in order to extract a single component  of executive functioning. Correlations 
(Spearman’s rank coefficient) between this EF factor and the  memory scores were then 
analyzed with age as a nuisance variable. 
 
Finally, to determine which specific measures  of EF significantly impact memory 
performance and to what extent, an automatic linear modeling  analysis was employed. 
 
Results 
 
Group comparisons 
 
Demographic and cognitive scores are  presented in  Table  1  and  Fig.  1,  as  well  as  
significant differences  observed  in  the  ANOVA  or  in  post hoc comparisons between 
groups. No differences on age and education were observed. Disease duration  and Mini-
Mental State Examination scores did not differ across  patients’  subgroups.  Controls 
outperformed patients on all cognitive measures. Patients did   not 
differ on digit spans and FAB scores, but  amnestic-bvFTD patients obtained lower fluency 
scores  than nonAmnestic-bvFTD patients. Results were identical after controlling for age. 
 
 
First step: Relationship between EF and memory processes 
 
Hierarchical clustering architecture 
 
Results from the hierarchical cluster analysis  are shown on Fig. 2. On these dendrograms, 
similar variables were joined at earlier stages (bottom of    each dendrogram), whereas 
those which were less similar were joined at later stages of the analysis (at the top). 
In the amnestic-bvFTD group (Fig. 2A), four distinct clusters   were   identified:   an    
attention/working-memory cluster composed from digit spans forward and backward, a 
pure EF cluster composed from FAB and semantic and lexical fluency, and two pure memory 
clusters, one composed from encoding, free recall and delayed free recall and finally, one    
composed from cued and delayed cued recall and recognition. In the nonAmnestic-bvFTD 
group (Fig. 2B), five clusters were identified: a pure EF cluster with FAB and fluency, an 
attention/working-memory cluster  with digit spans forward and backward, a pure   memory 
cluster with encoding, free and delayed free recalls, another memory cluster composed 
from cued recall and recognition, and an isolated delayed cued recall cluster. In the control 
group (Fig. 2C), one pure memory cluster was identified (composed from cued and 
delayed cued recalls), a pure executive cluster (span and fluency), an isolated recognition 
cluster and    a mixed cluster with encoding, free and delayed   free recalls as well as FAB. 
Correlations with the EF component 
 
In   the   amnestic-bvFTD   group, no  significant correlations  were  observed  between  the 
EF component   extracted   from   the principal  component analysis and the memory scores. 
In     non-amnestic patients, encoding was significantly correlated with the  EF  component  
(R = 0.50,  p < 0.05).  In   controls,   free   recall,   total   (free+cued)   recall, total (free+cued) 
delayed recall, and sensitivity to cueing were  significantly  correlated  with  the  EF 
component (respectively R = 0.27; R = 0.58; R = 0.32; and R = 0.52 all p < 0.05). Results were 
similar     when including age as a nuisance covariate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Performance (z-scores) of amnestic bvFTD, non-amnestic bvFTD and controls at (A) the Free and Cued 
Selective Reminding Test (FCSRT) for encoding, free recall, total recall, delayed free recall, delayed total recall 
and recognition subscores and (B) at the digit span forward & backward, semantic, and lexical verbal fluency 
and Frontal Assessment Battery (FAB) 
Fig. 2. Dendrogram using Ward’s linkage, showing the hierarchical cluster architecture of memory and 
executive scores for (A) amnestic bvFTD, (B) non-amnestic bvFTD and (C) controls. Green variables represent 
executive function measures and blue variables represent Free and Cued Selective Reminding Test (FCSRT) 
subscores. FAB, Frontal Assessment Battery. 
 
Table 1 
Demographics and neuropsychological tests 
differences between groups 
 
Amnestic 
bvFTD 
(n = 33) 
NonAmnestic 
bvFTD 
(n = 38) 
Controls (n = 60) Differences 
<0.01 
Demographics and screening test    
Age (years) 64.89 (13.71) 66.74 (9.35) 68.78 (7.05) N.S. 
Education (years) 11.15 (3.66) 11.67 (3.77) 12.81 (3.04) N.S. 
Disease duration (years) 3.41 (2.03) 3.27 (2.27) – N.S. 
MMSE (/30) 
Executive functioning 
Digit span forward 
24.42 (3.97) 
 
4.78 (0.94) 
23.03 (3.82) 
 
5.64 (1.47) 
29.22 (0.93) ∗, b, c 
5.82 (1.25) ∗ 
Digit span backward 3.07 (0.73) 3.68 (1.25) 4.07 (0.99) ∗, b 
FAB (/18) 11.10 (3.60) 13.20 (2.91) 16.95 (1.17) ∗, b, c 
Lexical fluency 4.90 (3.66) 7.47 (3.76) 19.00 (6.10) ∗, a, b, c 
Semantic fluency 
Memory processes (FCSRT) 
9.03 (4.01) 13.31 (4.37) 25.37 (10.14) ∗, a, b, c 
Encoding (/16) 10.84 (3.84) 14.57 (1.73) 15.42 (0.78) ∗, a, b 
Free recall (/48) 10.12 (6.20) 20.32 (5.84) 31.36 (5.52) ∗, a, b, c 
Cued recall (/48) 17.45 (7.57) 23.84 (4.85) 15.05 (5.06) ∗, a, b, c 
Total recall (/48) 27.58 (9.94) 44.16 (3.17) 46.41 (1.85) ∗, a, b, c 
Sensitivity to cues (%) 47.21 (18.83) 86.78 (9.94) 90.76 (11.11) ∗, a, b 
Delayed free recall (/16) 2.54 (2.19) 7.00 (2.66) 11.71 (2.22) ∗, a, b, c 
Delayed cued recall (/16) 6.61 (3.11) 8.06 (1.93) 4.02 (2.11) ∗, b, c 
Delayed total recall (/16) 9.43 (4.06) 15.06 (1.37) 15.73 (0.52) ∗, a, b 
Recognition (/16) 14.89 (1.49) 15.62 (1.72) 16 (0) ∗, a, b, c 
 
Maximum test scores (where applicable) indicated in brackets; Mean (Standard deviation). N.S., 
non-significant; MMSE, Mini-Mental State Examination; FAB, Frontal Assessment Battery; FCSRT, 
Free and Cued Selective Reminding Test. ∗p < 0.01 for ANOVA; ap < 0.01 between bvFTD subgroups; 
bp < 0.01 between Controls and amnestic patients; cp < 0.01 between controls and non-amnestic 
patients. 
 
Second step: Inﬂuence of EF measures on 
bvFTD’s memory performance 
 
Automatic linear modeling 
 
In  order  to  explore  which  EF  measure   could influence  the  memory  performance  in  
bvFTD, all EF  measures  were  entered  in  an  automatic linear model as predictor variables 
and each memory score was sequentially considered as the target    variable. This analysis 
was run in both bvFTD subgroups.  In amnestic-bvFTD, the results showed that the     only 
memory  score  to  be  significantly  (p < 0.05)  predicted by EF performance was free recall, 
but to    a minor extent (12.7% of its variance was    predicted by semantic fluency 
performance). EF also appeared to influence encoding and total recall  performances 
(respectively predicting 4.5% and 4.6% of variance), but this link was non significant. EF did 
not influence any of the remaining processes (namely    free and total delayed recalls, 
recognition and    sensitivity to cues). In non-amnestic bvFTD, no  significant effect of EF 
performance on memory processing was observed. Although EF  influenced  encoding, free 
4.3%, 4.3% and 6.8% of their variance), this failed to reach statistical significance. 
 
Discussion 
 
These  data-driven  results  clearly  show  that, in bvFTD, memory processes were overall 
independent from executive functioning regardless of the amnestic presentation of the 
disease. First, the   clustering approach shows how memory scores were   distinct from 
executive measures in both amnestic and non-amnestic presentation of bvFTD. By contrast,    
this relationship between EF and memory was stronger in controls, as the FAB clustered 
with encoding   as well as free and delayed recall. In line with this result, the correlation 
analysis showed that,     while the EF component extracted from the principal component 
analysis was not correlated with any of   the memory  scores  in  amnestic-bvFTD,  it  was 
correlated  with  encoding  performance  in non-amnestic patients and with free recall, total 
recall,  sensitivity to cueing, and free delayed recall scores in controls. Taken together, these 
results suggest that   memory performance in bvFTD is largely independent from executive 
functioning, while it is correlated with EF in healthy elderly controls. This indicates that 
memory and executive function in bvFTD might be more independent than previously 
thought and that the episodic amnesia observed in   amnestic-bvFTD cannot be solely 
explained by an impairment of executive/prefrontal functions alone. 
 
In a second step, we investigated the specific contribution of EF measures on memory 
performance in  bvFTD  through  an  automated  linear modelling approach. By contrast to 
the clustering and  correlation analyses, this approach considered each memory score 
independently from the others, allowing a more specific investigation of which EF score 
contributed to which memory process. We observed that in both amnestic and non-
amnestic subgroups of bvFTD, the influence of EF was negligible. In sum,  converging 
evidences from the different statistical    approaches showed that the contribution of EF on 
memory processes is not only weaker that what was assumed in bvFTD, but also 
qualitatively different from what was expected. 
 
Numerous  studies  have  demonstrated  that  pre-frontal cortex is critical in various aspects 
of episodic memory, such as encoding and retrieval [15, 17, 18, 27, 28]. In more detail, it has 
been suggested that PFC dysfunction disrupts the executive processes involved in voluntary 
encoding and retrieval processes     and particularly in the organization of information  
necessary for an optimal encoding as well as the use and monitoring of efficient retrieval 
strategies needed to recall these information [28]. This view is shared by many authors who 
consider  executive/prefrontal processes as critically involved in memory  processing [29, 
30]. Historically, these conceptions explain why the memory deficits observed in bvFTD   
were exclusively  attributed  to  executive/prefrontal dysfunctions [23, 24, 31]. Prefrontal 
atrophy is   indeed characteristic of bvFTD [32] and damage to this particular region has 
been related to core symptoms  of bvFTD, such as behavioral dysfunction, social cognition 
deficit or executive impairment [19, 33,   34]. In addition, several studies have observed     
significant relationship between PFC atrophy and memory performance in bvFTD [5, 35], 
although so far,    no study explored this link using tests that target the specific  processes  
of  episodic  memory.  The contribution  of  other  episodic  memory  structures has also to 
be investigated in bvFTD. Indeed, in bvFTD, significant postmortem pathology occurs in the 
hippocampus, even in patients dying early during    the course  of  the  disease  [36,  37]  and  
recent  in  vivo investigations have shown that atrophy of the    hippocampus could be as 
severe in bvFTD than it is  in AD [11, 13]. Furthermore, one  neuropsychological investigation 
of memory performance in bvFTD with biological evidence of the diagnosis has shown that 
memory storage and consolidation  processes—that are  hippocampus-mediated 
processes—could  also be impaired in bvFTD [9]. Taken  together with     a previous  study  
having  highlighted  the correlation between episodic memory deficit and  hippocampal 
degeneration in bvFTD [38], this highlight a broader involvement of atrophy within the 
brain, thus including other regions such as the hippocampus. 
 
In  line  with  these  results,  we  believe  that our findings  in  amnestic  and  non-amnestic 
subgroups of  bvFTD  reflect  different  PFC  and hippocampal integrity.  While  both 
amnestic  and  non-amnestic patients presented with executive dysfunction characteristic of 
a PFC involvement, only the    memory profile of amnestic-bvFTD patients revealed a typical 
pattern of hippocampal atrophy, with storage and consolidation deficit [39, 40]. 
Consecutively, it may explain why the relationship between EF impairment and encoding 
difficulties is closer in   non-amnestic patients than it is in amnestic patients. Indeed,    EF 
impairment and encoding deficits may rely on    the same PFC involvement in non-amnestic 
patients. By contrast, this relationship is weak in amnestic patients as EF and memory deficit 
are related to the involvement of different brain regions, respectively the PFC and the 
hippocampus. By extension, the stronger relationship between EF and memory in controls    
may reveal a stronger dependency of memory processing on EF,  which support strategic 
aspects of   episodic memory. It may also reflect the subtle and    normal age-related  
cognitive  decline  affecting  both executive and memory functioning [41–44] as well as 
prefrontal and hippocampal age-related grey   mater loss  (for  a  review,  see  [45]).  Taken  
together, this different  normal  and  pathological  neural involvement  would  explain  why  
the  contribution  of  EF seems to decrease as a function of amnestic impairment, as it 
seems more important in controls than in non-amnestic patients and more important in 
non-amnestic patients than in amnestic patients. In sum, the results of the present study 
highlight that EF involvement has only a negligible influence on   the memory impairments 
observed in bvFTD, in contrary to what was previously thought. These results   also show 
that bvFTD patients could suffer from a  genuine amnesia characterized by a deficit in   
memory storage and consolidation that could not be explained by EF deficits or PFC 
involvement but are more likely to be attributed to the hippocampus degeneration that 
could be observed in this disease. 
 
This  study  has  clear  clinical  implications.   At present, the relative preservation of episodic 
memory and the presence of executive dysfunctions are among the diagnostic criteria of 
bvFTD [2]. Thus, not only the episodic amnesia in bvFTD is underestimated but it is also 
presumed to be predominantly    explained by executive dysfunction. Our finding contradict 
this idea by showing that, in a bvFTD population where the  majority  of  patients  have  
biomarkers supporting the diagnosis, EF has only a little influence   on memory  
performance,  in  both  amnestic  and non-amnestic form of the disease. These findings also 
suggest that, although the FCSRT was proposed   as a useful clinical diagnostic tool to 
objectively assess the presence of an episodic amnesia in AD [46], caution should be 
observed when interpreting results for the purpose of differential diagnosis for bvFTD. This 
highlights the importance of a diagnosis relying on a clinical-biological entity supported by 
the  evidence of positive pathophysiological biomarker. However, as such examination are 
not always possible, one possibility is that the FCSRT can be used alongside tests of social 
cognition (like the mini-Social    cognition & Emotional Assessment) that have been shown  
to reliably distinguish bvFTD from AD regardless   of amnestic presentation of bvFTD [25]. 
Another neuropsychological way of distinguishing bvFTD from AD is the use of spatial 
navigation tests, which have been found to be specifically impaired in AD [49]. 
 
This study is to date, the first data-driven investigation of the relationship between EF and 
memory processes bvFTD by taking the level of amnesia into account. Despite describing 
this relationship through converging statistical evidence on large groups     of bvFTD patients 
and controls, our approach was limited by the range of the neuropsychological tests that 
we used. Similarly, in this study, we clubbed phonemic and category fluency under 
executive measures; even though these tests rely on executive processes, they also rely 
heavily on other non-executive    cog- studies should use a larger range of EF measures 
to extend our findings, especially in including   neuropsychological EF tests that tap into PFC 
subregions that  may  not  be  measured  by  the  tests  that   we used, such as the ventral 
parts of the PFC. As an example,  the  Hayling  test  which  taps  into  more ventral  lateral  
and  medial  PFC  regions  [33,  47] could be particularly interesting to relate to memory 
processes as these PFC regions have been   also shown  to  be  involved  in  episodic  
encoding  and semantic retrieval [48]. Finally, future investigations of  the  FCSRT  would  
benefit  from  incorporating structural or functional neuroimaging to clarify the neural 
mechanisms underlying memory performance in bvFTD. Despite these shortcomings, the    
results should further improve the diagnostics and   disease management of bvFTD. 
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